Hims is a well-established telehealth platform with strong brand recognition and a broad multi-condition product range. Its compounded semaglutide program is priced at approximately $79 to $199 per month depending on dose tier and plan configuration. The advertised starting price of $79/month applies only at the lowest starting dose — patients who reach and stabilize at therapeutic maintenance doses typically pay $149 to $199 per month or more.
Luma Health offers compounded semaglutide at $197/month flat — the same active ingredient, at a rate that does not change as your dose increases, with no contracts, no consultation fees, and free shipping. At maintenance doses where most patients spend the majority of their treatment time, Luma Health is competitive with or less expensive than Hims while offering greater pricing predictability and transparent pharmacy credentials.
What Is Hims and How Does Its GLP-1 Program Work?
Hims & Hers is one of the most recognized names in direct-to-consumer telehealth in the United States, built on a direct-to-consumer model that covers hair loss, sexual health, skincare, mental health, and more recently, weight management. The company's consumer-facing brand is polished and heavily marketed, which is both an asset for awareness and a cost that gets baked into program pricing.
Hims' weight loss program offers compounded semaglutide — the same active pharmaceutical ingredient as Wegovy and Ozempic — through a telehealth intake and compounding pharmacy fulfillment model. Patients complete a health questionnaire, a licensed provider reviews their intake and prescribes if eligible, and medication is shipped directly to their door. The clinical model is functionally similar to most GLP-1 telehealth platforms in the market.
What distinguishes Hims in the GLP-1 space is primarily brand recognition, platform design quality, and broad consumer reach — not a fundamentally different clinical approach. Hims' providers are licensed US practitioners, the medication is compounded semaglutide from licensed pharmacies, and the eligibility criteria follow the same FDA-aligned standards used across the market (BMI ≥30, or BMI ≥27 with a weight-related comorbidity).
Hims Semaglutide Pricing: Dose Tier by Dose Tier
Hims uses a dose-dependent pricing model for its semaglutide program — meaning the monthly cost increases as patients titrate upward through the standard escalation protocol. The $79/month starting price that appears in Hims' advertising applies at the lowest starting dose. As patients follow the clinically recommended titration schedule over three to five months to reach therapeutic maintenance doses, the monthly cost increases accordingly.
| Semaglutide Dose | Treatment Phase | Hims Est. Monthly Cost | Luma Health Monthly |
|---|---|---|---|
| 0.25 mg/week | Starting dose (weeks 1–4) | ~$79/mo | $197/mo |
| 0.5 mg/week | Titration (weeks 5–8) | ~$99–$129/mo | $197/mo |
| 1.0 mg/week | Mid-titration (weeks 9–16) | ~$129–$149/mo | $197/mo |
| 1.7 mg/week | Higher maintenance | ~$149–$179/mo | $197/mo |
| 2.4 mg/week | Full maintenance | ~$179–$199/mo | $197/mo |
| Est. 12-month total (with escalation) | ~$1,500–$2,400 | $2,364 (flat) | |
Hims pricing estimates are based on publicly available rates as of June 2026. Actual costs may vary by plan configuration and any promotional pricing in effect at enrollment. Annual total assumes standard titration with 2 months at starting dose and 8 months at or near maintenance. Verify current pricing at hims.com before enrolling.
The most important observation from this table is the competitive positioning at different treatment phases. At starting doses (months one and two), Hims' $79/month is significantly lower than Luma Health's $197/month flat rate. At mid-titration (months three through five), Hims is approaching parity with Luma. At maintenance doses (months six through twelve-plus), Hims at $179 to $199 per month is comparable to or slightly higher than Luma Health's flat $197/month — with the key difference being that Luma's price is guaranteed not to change, while Hims' maintenance-dose pricing may vary by plan tier and configuration.
Hims' Hidden and Variable Costs
Beyond the dose-tier pricing structure, several additional cost categories can affect what Hims patients actually pay relative to what Hims' advertising communicates. These are not unique to Hims — they reflect common practices across the telehealth GLP-1 market — but they are worth identifying explicitly before enrollment.
Introductory vs. Ongoing Pricing
Hims periodically offers promotional or introductory rates for new enrollments. The price that appears in advertising materials may reflect a first-month or first-quarter promotional rate that increases once the promotional period expires. Always ask explicitly what the ongoing post-promotional price is before enrolling based on an advertised rate.
Commitment-Based Pricing
Hims' lowest per-month rates often require 3 to 6 month prepaid commitments. Month-to-month billing without a commitment is available but typically more expensive on a per-month basis. If you prepay for a 3 or 6-month plan and need to stop treatment early, refund eligibility for unused months depends on Hims' cancellation policy at the time of enrollment.
Consultation Fee Variability
Hims' consultation fee structure has varied over time and by plan tier. Some configurations bundle consultation costs into the monthly medication price; others charge a separate initial or per-visit fee. As of 2026, most Hims weight loss subscription plans include consultations, but verifying this for your specific plan before enrolling is important.
Dose Change and Plan Modification
Changing your dose tier, pausing your subscription, or modifying your plan may involve administrative changes that affect your billing cycle and potentially your monthly rate. Patients who need a dose hold due to side effects or who want to escalate more quickly than the standard schedule may encounter plan modification processes that affect billing.
Shipping Variability
Hims includes standard shipping on most GLP-1 plans, but some configurations or expedited shipping requests may carry additional fees. Verify specifically whether shipping is included in your plan at all dose tiers before assuming it is always free.
Early Cancellation of Commitment Plans
If you enrolled in a multi-month prepaid plan to access Hims' lower per-month rate, understand the refund policy before signing up. Some commitment plans do not offer refunds for unused months if treatment is discontinued early. Luma Health's month-to-month model eliminates this risk entirely — you never pay for more than one month at a time.
True 12-Month Cost Comparison: Hims vs. Luma Health
The annual cost comparison is more nuanced than the starting-price comparison. At the bottom end of Hims' estimated range ($1,500), Hims is less expensive than Luma Health's flat $2,364. At the top end of Hims' range ($2,400), the costs are essentially equivalent. The critical question is not which number appears lower in the comparison table — it is which number reflects what patients actually pay when commitment plan pricing, promotional rate expiration, and maintenance-dose pricing are factored in for your specific situation.
Luma Health's advantage is certainty: $197/month is what you pay in month one, month six, and month twelve, regardless of which dose you are on, with no promotional period expiration and no commitment required. For patients who value that predictability over the possibility of paying slightly less in the first one to two months, Luma's flat rate is the more reliable budgeting tool.
Hims vs. Luma Health: Platform Comparison
What Does Hims' Higher Brand Premium Pay For?
Understanding what Hims' marketing investment buys — and whether it adds clinical value — helps patients decide whether the Hims brand is worth paying for relative to alternatives. Hims has invested heavily in consumer brand building, advertising across digital, television, and streaming platforms, and platform design. Their product interfaces are well-designed and polished. Their customer support infrastructure is substantial.
None of these investments affect the pharmacology of the compounded semaglutide in the vial. The medication that arrives from Hims' compounding pharmacy partner and the medication that arrives from Luma Health's pharmacy (VialsRX) contain the same active ingredient at equivalent doses. The clinical outcomes — appetite suppression, weight loss trajectory, side effect profile — are determined by the semaglutide molecule and your individual response to it, not by the UX design of the platform that issued the prescription.
For patients who place significant value on brand recognition, a polished app experience, or the reassurance of a larger well-known company, Hims' premium may feel justified. For patients whose primary consideration is medication cost, pharmacy transparency, and predictable monthly pricing, Hims' brand investment represents overhead they are paying for without receiving additional clinical benefit.
How to Choose Between Hims and Luma Health
The decision between Hims and Luma Health for GLP-1 treatment is ultimately a function of what you prioritize and what your treatment timeline looks like. It is not a question of which provider is categorically better — both are legitimate, both use licensed US providers, both prescribe compounded semaglutide from licensed pharmacies. The question is which provider's pricing structure and program design is the better fit for your individual situation.
Choose Hims if you are starting treatment with genuine uncertainty about whether you will continue beyond the first one to two months and want to minimize cost during that evaluation window. Hims' $79/month starting price is lower than Luma's $197/month flat rate, which means less financial commitment in the period when you are testing tolerance and early results. Hims is also the right choice for patients who place high value on the brand recognition and platform design quality that Hims has built.
Choose Luma Health if you are entering treatment with a clear 6 to 18-month horizon and want the most price-predictable, pharmacy-transparent, no-contract program at competitive maintenance-dose pricing. Luma Health's $197/month flat rate is comparable to Hims at maintenance doses, with the significant advantage that it is guaranteed not to change as your dose escalates. For patients who have already spent a month or two on Hims and are now approaching maintenance doses, switching to Luma Health locks in pricing certainty for the remaining majority of the treatment course.
Frequently Asked Questions
How much does Hims semaglutide cost per month in 2026?
Hims semaglutide pricing in 2026 ranges from approximately $79 per month at the lowest starting dose to $179 to $199 per month at therapeutic maintenance doses. The advertised starting price of $79/month is the lowest available tier and applies only for the first one to two months of treatment before dose escalation begins. Patients who reach and stabilize at a 2.4 mg weekly maintenance dose typically pay $179 to $199 per month, depending on their plan configuration and whether they are on a commitment plan or month-to-month billing. Always verify current pricing directly at hims.com before enrolling.
Does Hims have hidden fees for semaglutide?
The most significant pricing surprise for Hims patients is typically not a hidden fee per se but a structural one: the promotional introductory rate that appears in advertising increases after the promotional period expires, and the maintenance-dose price that applies for most of the treatment year is significantly higher than the starting rate. Some patients also encounter consultation fees on certain plan configurations or additional charges when modifying their plan. Before enrolling, ask Hims specifically: what is the monthly price at each dose tier, what is the price after any promotional period expires, and are consultations and shipping included at all tiers?
Is Hims semaglutide the same as Wegovy?
Not exactly. Hims prescribes compounded semaglutide — which contains the same active pharmaceutical ingredient as Wegovy (semaglutide, developed by Novo Nordisk) — but is produced by a licensed 503A compounding pharmacy rather than by Novo Nordisk. Compounded semaglutide is not an FDA-approved drug product as a finished medication, but the active ingredient itself is FDA-approved in Wegovy. The pharmacological mechanism, expected weight loss outcomes, and side effect profile are equivalent when the compounded medication is correctly formulated. Hims' compounded semaglutide is not Wegovy; it is a compounded preparation containing the same active molecule at equivalent doses.
Does Hims require a contract for semaglutide?
Hims offers both month-to-month and multi-month commitment plan options for its semaglutide program. The commitment plans (3 or 6 months prepaid) offer lower per-month pricing compared to month-to-month billing. If you sign up for a commitment plan and need to discontinue treatment early, refund eligibility for unused months depends on Hims' cancellation policy. Month-to-month plans offer flexibility without the financial risk of commitment plans. Luma Health is uniformly month-to-month with no commitment options — you pay for one month at a time regardless of your dose or length of enrollment.
How does Hims semaglutide compare to Luma Health?
Both Hims and Luma Health offer compounded semaglutide from licensed 503A compounding pharmacies through telehealth prescribing. The medications contain the same active ingredient. The primary differences are: pricing structure (Hims uses dose-tier pricing from $79 to $199/month; Luma Health uses a flat $197/month regardless of dose); pharmacy transparency (Hims does not consistently disclose pharmacy identity publicly; Luma uses VialsRX with a publicly verifiable TX Board license #35264); contract terms (Hims offers commitment plan options; Luma is uniformly month-to-month); and brand recognition (Hims is a larger, more established consumer brand; Luma is a GLP-1-focused provider with a narrower specialization). At starting doses, Hims is less expensive. At maintenance doses, the two providers are comparable in price with Luma offering greater predictability.
Can I use HSA or FSA funds for Hims or Luma Health semaglutide?
Compounded semaglutide for weight management prescribed by a licensed provider may be eligible for HSA (Health Savings Account) or FSA (Flexible Spending Account) reimbursement, though eligibility depends on your specific account administrator's policies. The IRS considers prescription medications generally eligible for HSA/FSA, but account administrators vary in how they handle telehealth and compounded prescriptions. Contact your HSA/FSA administrator directly to verify eligibility before planning to use these funds. Neither Hims nor Luma Health accepts insurance for their GLP-1 programs; both are cash-pay only.
What is Hims' semaglutide pharmacy?
Hims uses licensed 503A sterile compounding pharmacies to prepare their compounded semaglutide. The specific pharmacy name and state pharmacy board license number are not consistently displayed on Hims' consumer-facing website — patients who want to verify the pharmacy credentials typically need to contact Hims customer support directly. By contrast, Luma Health uses VialsRX, a 503A licensed sterile compounding pharmacy in Houston, TX, with a Texas State Board of Pharmacy license (license #35264) that is publicly verifiable at pharmacy.texas.gov without requiring any customer support inquiry.
Should I choose Hims or Luma Health for GLP-1?
If you are in an evaluation phase and want the lowest possible cost for your first one to two months before committing to long-term treatment, Hims' $79/month starting price offers a lower-cost entry point. If you are entering treatment with a 6 to 18-month commitment horizon and want flat-rate pricing certainty, independently verifiable pharmacy credentials, and no contract risk, Luma Health is the stronger choice. The decision is primarily about treatment timeline and what you value in a GLP-1 provider — both are legitimate options for the right patient, and the pharmacological outcome from the same active ingredient will be the same regardless of which platform issues the prescription.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- Rubino DM, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- FDA. Wegovy (semaglutide) Prescribing Information. 2023. FDA.gov
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- IRS. Publication 502: Medical and Dental Expenses (HSA/FSA Eligible). IRS.gov